CN1255149C - Combination of medication - Google Patents
Combination of medication Download PDFInfo
- Publication number
- CN1255149C CN1255149C CN 200410051043 CN200410051043A CN1255149C CN 1255149 C CN1255149 C CN 1255149C CN 200410051043 CN200410051043 CN 200410051043 CN 200410051043 A CN200410051043 A CN 200410051043A CN 1255149 C CN1255149 C CN 1255149C
- Authority
- CN
- China
- Prior art keywords
- radix
- present
- ginseng
- panax notoginseng
- kilograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medical composition which is composed of 10 to 30 wt% of water plantain, 5 to 25 wt% of panax notoginseng, 5 to 25 wt% of panax notoginseng, 5 to 25 wt% of ginseng, 5 to 20 wt% of American ginseng, 10 to 35 wt% of red sage root and 3 to18 wt% of hawthorn, wherein the selected panax notoginseng and red sage root have good function of dispelling stasis; the water plantain and hawthorn have the function of reducing blood fat; the ginseng and American ginseng have the functions of promoting fluid production, inducing sedation and preventing stasis and medicated deviation. The present invention has the efficiency of reducing blood fat and dredging blood vessels and has the obvious effect on reducing triglyceride in the blood serum of a human body.
Description
Technical field
The present invention relates to a kind of medicine with blood fat reducing promoting blood circulation.
Background technology
At present, have in the pure Chinese medicinal preparation of blood fat reducing promoting blood circulation, DASHANZHA WAN, arteries and veins peace electuary etc. are arranged, it exists the effect of triglyceride reducing not remarkable, and day is taken medicine problem often.By retrieval, find no identical with the present invention or similar medicine report.
Summary of the invention
Purpose of the present invention just provides a kind of medicine with blood fat reducing promoting blood circulation.
The present invention can be realized by following mode: the present invention is made up of following compositions, and its percentage by weight is: Rhizoma Alismatis 10～30%, Radix Notoginseng 5～25%, Radix Ginseng 5～25%, Radix Panacis Quinquefolii 5～20%, Radix Salviae Miltiorrhizae 10～35%, Fructus Crataegi 3～18%.
The Radix Notoginseng that the present invention chooses, Radix Salviae Miltiorrhizae have good blood stasis dispelling effect, and Rhizoma Alismatis, Fructus Crataegi be the energy blood fat reducing all, Radix Ginseng, Radix Panacis Quinquefolii promoting the production of body fluid and inducing sedation of the mind, and the anti-blood stasis dispelling property of medicine is inclined to one side.The present invention has the effect of blood fat reducing promoting blood circulation, and triglyceride has significant effect in the human serum to reducing.
The present invention is used for the treatment of the clinical efficacy of hyperlipidemia
It is treatment target that triglyceride surpasses the above person of 160mg/100ml.
Diagnostic criteria: (1) produce effects: more than the triglyceride decline 65mg/100ml, and reduce to normal range.(2) effective: (i) triglyceride is declined by less than 65mg/100ml, but reduces to normal range; (ii) more than the triglyceride decline 65mg/100ml, but do not reach normal range.(3) invalid: as not reach above standard person.
Therapeutic outcome: carry out clinical trial 30 examples with this medicine, by above-mentioned diagnostic criteria evaluation, the result is: produce effects 16 examples, effective 10 examples, invalid 4 examples.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment one
Get 30 kilograms of Rhizoma Alismatis, 25 kilograms in Radix Notoginseng, 25 kilograms of Radix Ginsengs, 5 kilograms of Radix Panacis Quinquefoliis, 10 kilograms of Radix Salviae Miltiorrhizaes, Fructus Crataegi and clean respectively for 5 kilograms, 50 ℃ of dryings are pulverized, and cross 120 mesh sieves, and mix homogeneously incapsulates, and obtains medicine.
Embodiment two
Get 10 kilograms of Rhizoma Alismatis, 9 kilograms in Radix Notoginseng, 8 kilograms of Radix Ginsengs, 20 kilograms of Radix Panacis Quinquefoliis, 35 kilograms of Radix Salviae Miltiorrhizaes, Fructus Crataegi and clean respectively for 18 kilograms, 80 ℃ of dryings are pulverized, and cross 120 mesh sieves, and mix homogeneously incapsulates, and obtains medicine.
The present invention also can be made into powder, tablet, electuary, pill.
Claims (1)
1, a kind of pharmaceutical composition of blood fat reducing promoting blood circulation is characterized in that being made up of the pharmacodynamic raw materials of following percentage by weight:
Rhizoma Alismatis 10～30 Radix Notoginsengs 5～25 Radix Ginsengs 5～25
Radix Panacis Quinquefolii 5～20 Radix Salviae Miltiorrhizaes 10～35 Fructus Crataegis 3～18.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410051043 CN1255149C (en) | 2004-08-09 | 2004-08-09 | Combination of medication |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410051043 CN1255149C (en) | 2004-08-09 | 2004-08-09 | Combination of medication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1626221A CN1626221A (en) | 2005-06-15 |
| CN1255149C true CN1255149C (en) | 2006-05-10 |
Family
ID=34763982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410051043 Expired - Fee Related CN1255149C (en) | 2004-08-09 | 2004-08-09 | Combination of medication |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1255149C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101366884B (en) * | 2008-09-26 | 2010-05-12 | 茂祥集团吉林制药有限公司 | Preparation technique for compound formulation for reducing blood fat and blood sugar |
| CN106420899A (en) * | 2016-11-17 | 2017-02-22 | 北京未医堂健康科技有限公司 | Ginseng pseudo-ginseng pill for benefiting qi and nourishing blood and preparation method thereof |
-
2004
- 2004-08-09 CN CN 200410051043 patent/CN1255149C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1626221A (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1148211C (en) | Medicine for treating congestive heart failure | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN1129577A (en) | Pellets for curing tinea | |
| CN102614387A (en) | Traditional Chinese medicine for prevention and treatment of stroke and preparation method thereof | |
| CN1255149C (en) | Combination of medication | |
| CN101214365B (en) | Chinese medicine composing prescription for treating mastoproliferation | |
| CN1160108C (en) | Medicine for treating cholecystitis and its preparing process | |
| CN1907353A (en) | Chinese traditional medicine preparation for treating chronic gastritis | |
| CN1723950A (en) | Traditional Chinese medicine for treating hyperlipidemia and its complicating diseases | |
| CN1772180A (en) | Chinese herbal medicine decoction for treating Yin-deficiency low fever and its prepn | |
| CN1399999A (en) | Medicine for curing malignant turnor and its preparation method | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
| CN1150942C (en) | Capsule for cleaning blood and reducing fat | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN1176690C (en) | Medicine for treating chronic nephritis | |
| CN1704071A (en) | Chinese medicine for treating chronic nephritis | |
| CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque | |
| CN1322558A (en) | Liver cancer resisting medicine | |
| CN1695639A (en) | Chinese traditional medicine for treating dysmenorrhea and irregular menses, and preparation method | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN1772179A (en) | Chinese herbal medicine decoction for treating wetness type low fever and its prepn | |
| CN102225132A (en) | Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof | |
| CN1772154A (en) | Chinese herbal medicine decoction for treating premenstrual abdominal pain and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |